Real-time notification reduces time to therapy by 3 hours for C diff patients

A study, published in the American Journal of Infection Control, examined the impact of real-time notification of detection of toxigenic Clostridium difficile infection as a strategy for decreasing time to effective antimicrobial therapy.

Advertisement

Researchers conducted a single-center, retrospective cohort study at a 433-bed tertiary medical center in Kentucky. They examined patients treated for C. diff both before and after the implementation of a real-time provider notification system.

The study shows that the median time to initiation of effective antimicrobial therapy decreased from 5.75 hours prior to real-time notification system implementation to 2.05 hours post-implementation. The intervention also reduced the time from detection of C. diff to order entry of effective antimicrobial therapy in the patient’s EMR.

“The implementation of a real-time notification system to alert a pharmacist-led [antimicrobial stewardship program] of toxigenic CDI resulted in statistically significant shorter times to order entry and subsequent initiation of effective antimicrobial therapy and contact precautions,” study authors concluded.

More articles on healthcare quality: 
Study: Patient fall history can help predict future bone fractures 
Standardized handoff improves ICU provider preparedness, reduces early morning order entry 
Woman sues California hospital, claims physicians left 8-inch forceps inside her after surgery

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.